INS and Obesity: By contrast, natriuretic peptides are deficient in obesity and diabetes, as obese and insulin-resistant individuals display reduced circulating ANP and BNP levels [34, 35], despite the fact that these metabolic disorders increase the risk of developing cardiovascular disease and heart failure.